UnitedHealth Q3 Adjusted EPS $4.69 Beats Expectations
UNH sits 52% above its 52-week low of $255.965.
Summary
UnitedHealth reported Q3 adjusted EPS of $4.56, beating expectations and continuing the company's pattern of beating consensus. The Q3 figure is the first hard number for the quarter and confirms the favorable medical cost trend. Earnings from operations were $6.6 billion, with days claims payable at 47.0. UnitedHealthcare served 48.3 million consumers, and Optum cared for more than 120 million patients and consumers. The medical care ratio was affected by $610 million of net favorable prior period reserve development related to 2026 dates of service. This follows the Q2 blowout of $6.38 versus $4.90 consensus and the raised full-year guidance.
At the time of this announcement, UNH was trading at $389.03 on NYSE in the Life Sciences sector, with a market capitalization of approximately $339.8B. The 52-week trading range was $255.97 to $461.62. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.